Beta Agonist Feed Additive Market Size and Share
Beta Agonist Feed Additive Market Analysis by Mordor Intelligence
The beta agonist feed additive market size is expected to increase from USD 1.27 billion in 2026 to USD 1.34 billion in 2027 and reach USD 1.79 billion by 2032, growing at a CAGR of 5.96% over 2027-2032. The beta-agonist feed additive market is experiencing robust growth, driven by increasing demand for high-quality meat production, improved animal growth performance, and enhanced feed efficiency. Widely utilized in the livestock industry, particularly in cattle and swine farming, beta-agonists help promote lean muscle growth, reduce fat deposition, and optimize feed utilization. The rising production of livestock is a key factor fueling market growth. For instance, the United States swine production increased from 75.0 million in 2022 to 75.8 million in 2023, according to FAOSTAT. Similarly, growing meat consumption has led to higher meat production in countries such as China, the United States, and Argentina. FAOSTAT data indicates that global beef production rose from 75.4 million metric tons in 2022 to 76.6 million metric tons in 2023. As demand for meat continues to surge, especially in emerging economies, livestock producers are increasingly adopting cost-effective solutions to enhance productivity and meet market needs. Furthermore, rising investments in precision livestock farming are contributing to the market’s expansion, creating new opportunities for industry players.
Note: Market numbers in this report are based on Mordor Intelligence's proprietary estimation framework, which combines nine months of actuals with Q4 projections for base year 2026.
Market Trends and Insights
Increasing Demand for Animal Meat to Drive Beta-Agonist Feed Additive Sales
The beta-agonist feed additive market is expanding in response to the growing pressure on the livestock industry to meet the rising global demand for meat and high-value animal protein. Factors such as population growth, increasing incomes in developing nations, and urbanization are driving a surge in livestock production. Higher income levels are closely linked to increased consumption of animal protein, with milk and meat becoming more prominent in diets at the expense of staple foods. Urbanization, in particular, has led to greater meat and dairy consumption in cities compared to rural areas. For example, according to the OECD, per capita pork consumption in Vietnam, China, and the United States rose in 2023 to 30.3 kg, 28.6 kg, and 21.8 kg, respectively, up from 30.0 kg, 28.0 kg, and 21.7 kg in 2022.
As the global meat market continues its steady growth, meat consumption is expected to register a significant CAGR over the forecast period. The Asia-Pacific and Latin American regions are projected to see the highest increases in meat consumption due to changing dietary patterns, urbanization, population expansion, and economic growth. For instance, China’s demand for meat continues to surpass domestic supply, as reported by Agriculture and Agri-Food Canada.
United States to Dominate the Beta Agonist Feed Additive Sales
The United States remains one of the key markets for beta-agonist feed additives, driven by strong meat consumption trends and the large-scale production of livestock. The increasing demand for high-quality beef and pork continues to stimulate cattle and swine production, further boosting the adoption of beta-agonist feed additives in the country.
In addition to cattle, the rising demand for pork has contributed to increased swine production, further supporting beta-agonist feed additive sales. According to FAOSTAT, US swine production reached 75.8 million in 2023, reflecting a 1.1% increase from the previous year. This steady growth in pork production highlights the ongoing need for feed-efficiency-enhancing additives to maximize output and profitability. With the US being one of the world’s largest consumers and exporters of meat, the beta-agonist feed additive market is projected to remain strong. Ongoing advancements in livestock nutrition, regulatory developments, and producer adoption of growth-promoting technologies will continue to shape market dynamics in the coming years.
Competitive Landscape
Market Concentration
The beta-agonist feed additives market is consolidated, with few major players offering similar products. The limited scope for product differentiation and innovation has resulted in a concentrated competitive landscape. Some of the major players in the country include Merck Animal Health, Elanco Animal Health, Zoetis, Quality Liquid Feed, and Heer Pharma Private Limited. New product launches following extensive R&D activities have been part of the strategic moves by the players.
Beta Agonist Feed Additive Industry Leaders
-
Merck Animal Health
-
Elanco Animal Health
-
Zoetis
-
Quality Liquid Feeds
-
Heer Pharma Private Limited
- *Disclaimer: Major Players sorted in no particular order
Beta Agonist Feed Additive Market Companies Covered in this Report
- Merck Animal Health
- Elanco Animal Health
- Zoetis
- Quality Liquid Feeds
- Heer Pharma Private Limited
Recent Industry Developments in Beta Agonist Feed Additive Market
- March 2024: The Animal Legal Defense Fund, Center for Biological Diversity, Center for Food Safety, and Food Animal Concerns Trust filed a lawsuit requiring the U.S. Food and Drug Administration (FDA) to respond to their 2012 and 2020 rulemaking petitions. These petitions called for reducing or eliminating permitted ractopamine levels in farmed animals.
Global Beta Agonist Feed Additive Market Report Scope
Beta-agonists are used as feed additives for ruminants and swine, especially before slaughter. They are approved feed additives, which help in escalating lean muscle gain, increasing growth rate, and improving feed efficiency. The Beta-Agonist Feed Additive Market Report Has Been Segmented by Type (Zilpaterol and Ractopamine), by Animal Type (Ruminants, Swine, and More), and by Geography (North America, Asia-Pacific, South America, and More). The Report Offers Market Size and Forecasts in Value (USD).
Segmentation Overview
| Ractopamine |
| Zilpaterol |
| Swine |
| Ruminants |
| Others |
| North America | United States |
| Canada | |
| Mexico | |
| Rest of North America | |
| Asia-Pacific | Japan |
| South Korea | |
| India | |
| Rest of Asia-Pacific | |
| South America | Brazil |
| Argentina | |
| Rest of South America | |
| Rest of the World |
| Type | Ractopamine | |
| Zilpaterol | ||
| Animal Type | Swine | |
| Ruminants | ||
| Others | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Rest of North America | ||
| Asia-Pacific | Japan | |
| South Korea | ||
| India | ||
| Rest of Asia-Pacific | ||
| South America | Brazil | |
| Argentina | ||
| Rest of South America | ||
| Rest of the World | ||
Key Questions Answered in the Report
How big is the Beta Agonist Feed Additive Market?
The Beta Agonist Feed Additive Market size is projected to reach USD 1.34 billion in 2027 and grow at a CAGR of 5.96% to reach USD 1.79 billion by 2032.
What is the Beta Agonist Feed Additive Market size in 2026?
In 2026, the Beta Agonist Feed Additive Market size is projected to reach USD 1.27 billion.
Who are the key players in Beta Agonist Feed Additive Market?
Merck Animal Health, Elanco Animal Health, Zoetis, Quality Liquid Feeds and Heer Pharma Private Limited are the major companies operating in the Beta Agonist Feed Additive Market.
Which is the fastest growing region in Beta Agonist Feed Additive Market?
Asia Pacific is the fastest growing region, forecast to grow at a CAGR of 7.2% from 2027 to 2032.
Which region has the biggest share in Beta Agonist Feed Additive Market?
In 2026, the North America accounts for the largest market share in Beta Agonist Feed Additive Market.